OneDigital Investment Advisors LLC Has $7.25 Million Holdings in Stryker Co. (NYSE:SYK)

OneDigital Investment Advisors LLC lowered its stake in shares of Stryker Co. (NYSE:SYK - Free Report) by 23.8% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 20,068 shares of the medical technology company's stock after selling 6,268 shares during the quarter. OneDigital Investment Advisors LLC's holdings in Stryker were worth $7,250,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of SYK. Sargent Investment Group LLC grew its stake in shares of Stryker by 26.4% during the third quarter. Sargent Investment Group LLC now owns 985 shares of the medical technology company's stock valued at $356,000 after buying an additional 206 shares during the last quarter. ING Groep NV grew its position in Stryker by 62.9% in the 3rd quarter. ING Groep NV now owns 124,854 shares of the medical technology company's stock valued at $45,105,000 after acquiring an additional 48,231 shares during the last quarter. Intelligence Driven Advisers LLC bought a new stake in shares of Stryker during the third quarter worth $246,000. Tokio Marine Asset Management Co. Ltd. boosted its stake in shares of Stryker by 3.2% during the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 9,417 shares of the medical technology company's stock valued at $3,402,000 after purchasing an additional 289 shares during the period. Finally, Sivik Global Healthcare LLC increased its stake in Stryker by 8.0% in the 3rd quarter. Sivik Global Healthcare LLC now owns 27,000 shares of the medical technology company's stock worth $9,754,000 after buying an additional 2,000 shares during the period. Hedge funds and other institutional investors own 77.09% of the company's stock.

Insider Activity

In related news, VP M Kathryn Fink sold 2,121 shares of the stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $370.00, for a total value of $784,770.00. Following the transaction, the vice president now owns 10,042 shares in the company, valued at approximately $3,715,540. This represents a 17.44 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Viju Menon sold 600 shares of the business's stock in a transaction that occurred on Tuesday, August 27th. The stock was sold at an average price of $355.00, for a total value of $213,000.00. Following the completion of the sale, the insider now owns 9,069 shares of the company's stock, valued at approximately $3,219,495. This trade represents a 6.21 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 67,381 shares of company stock worth $24,825,275. 5.90% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

SYK has been the subject of several recent research reports. Wells Fargo & Company lifted their price objective on Stryker from $381.00 to $405.00 and gave the company an "overweight" rating in a report on Wednesday, October 30th. Evercore ISI raised their price target on shares of Stryker from $380.00 to $384.00 and gave the stock an "outperform" rating in a research report on Wednesday, October 30th. Needham & Company LLC boosted their price target on Stryker from $393.00 to $409.00 and gave the company a "buy" rating in a report on Wednesday, October 30th. Canaccord Genuity Group boosted their price objective on Stryker from $360.00 to $400.00 and gave the company a "buy" rating in a research report on Wednesday, October 30th. Finally, JPMorgan Chase & Co. lifted their price objective on Stryker from $375.00 to $420.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 30th. Four equities research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $393.65.

Stryker Price Performance

SYK traded up $6.80 during midday trading on Friday, reaching $390.08. 2,826,370 shares of the company's stock were exchanged, compared to its average volume of 1,266,685. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.91 and a quick ratio of 1.22. Stryker Co. has a 1-year low of $282.35 and a 1-year high of $392.70. The business's 50-day moving average price is $363.45 and its 200 day moving average price is $346.97. The stock has a market capitalization of $148.71 billion, a PE ratio of 41.26, a P/E/G ratio of 2.93 and a beta of 0.91.

Stryker (NYSE:SYK - Get Free Report) last released its quarterly earnings data on Tuesday, October 29th. The medical technology company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.77 by $0.10. Stryker had a return on equity of 23.07% and a net margin of 16.34%. The business had revenue of $5.49 billion for the quarter, compared to analyst estimates of $5.37 billion. During the same period in the previous year, the company posted $2.46 EPS. The company's revenue was up 11.9% compared to the same quarter last year. As a group, equities analysts anticipate that Stryker Co. will post 12.06 EPS for the current fiscal year.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.